{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:47:07Z","timestamp":1777441627789,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.dld.2004.12.016","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T09:54:58Z","timestamp":1113472498000},"page":"485-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD\u2014crossover comparative study with famotidine and low-dose lansoprazole"],"prefix":"10.1016","volume":"37","author":[{"given":"K.","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Komazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2004.12.016_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/BF02065545","article-title":"How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease?","volume":"40","author":"Ghillebert","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2004.12.016_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0016-5085(95)90351-8","article-title":"Transient lower esophageal sphincter relaxation","volume":"109","author":"Mittal","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.12.016_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/gut.33.1.118","article-title":"Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease","volume":"33","author":"Bell","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.dld.2004.12.016_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.1875-9114.1997.tb03675.x","article-title":"Proton pump inhibitors and acid-related diseases","volume":"17","author":"Sachs","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.dld.2004.12.016_bib5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1365-2036.1999.00656.x","article-title":"Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group","volume":"13","author":"Jansen","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.12.016_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1440-1746.2002.02785.x","article-title":"Randomized comparative study of omeprazole and famotidine in reflux esophagitis","volume":"17","author":"Kawano","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2004.12.016_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2036.1994.tb00278.x","article-title":"Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole","volume":"8","author":"Hurlimann","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.12.016_bib8","first-page":"351","article-title":"Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72hours","volume":"94","author":"Netzer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2004.12.016_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1572-0241.2000.01701.x","article-title":"Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration","volume":"95","author":"Lachman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2004.12.016_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1440-1746.2003.03041.x","article-title":"Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subject without Helicobacter pylori infection","volume":"18","author":"Komazawa","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl. 6","key":"10.1016\/j.dld.2004.12.016_bib11","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0016-5085(97)80010-8","article-title":"Review article: How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology","volume":"113","author":"Calam","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.12.016_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2036.2004.02147.x","article-title":"Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists","volume":"20","author":"Fujisawa","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.12.016_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2004.12.016_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s005350200115","article-title":"Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection","volume":"37","author":"Adachi","year":"2002","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2004.12.016_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1083-4389.2002.00064.x","article-title":"Cardiovascular risk factors in subjects with Helicobacter pylori infection","volume":"7","author":"Takashima","year":"2002","journal-title":"Helicobacter"},{"issue":"Suppl. 199","key":"10.1016\/j.dld.2004.12.016_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00365529309098350","article-title":"Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases","volume":"28","author":"Dimenas","year":"1993","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl. 221","key":"10.1016\/j.dld.2004.12.016_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/00365529609095544","article-title":"Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease","volume":"31","author":"Dimenas","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl. 231","key":"10.1016\/j.dld.2004.12.016_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/003655299750025264","article-title":"Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic\/International Gastroenterology Surveillance Study (DIGEST)","volume":"34","author":"Enck","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2004.12.016_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archinte.161.1.45","article-title":"The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life","volume":"161","author":"Farup","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2004.12.016_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0149-2918(97)80053-7","article-title":"The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion","volume":"19","author":"Blum","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.dld.2004.12.016_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2036.1999.00531.x","article-title":"The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine","volume":"13","author":"van Herwaarden","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.12.016_bib22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1440-1746.2001.02617.x","article-title":"Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis","volume":"16","author":"Adachi","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2004.12.016_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1572-0241.2001.03679.x","article-title":"Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease","volume":"96","author":"Tefera","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2004.12.016_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.1998.221_a.x","article-title":"Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors","volume":"93","author":"Peghini","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2004.12.016_bib25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1365-2036.2000.00799.x","article-title":"Helicobacter pylori infection influences nocturnal gastric acid breakthrough","volume":"14","author":"Katsube","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.12.016_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.dld.2003.09.003","article-title":"Unsolved problems in the management of patients with gastro-oesophageal reflux disease","volume":"35","author":"Stanghellini","year":"2003","journal-title":"Dig Liver Dis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865805000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865805000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:07:48Z","timestamp":1761624468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865805000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1590865805000976"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2004.12.016","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD\u2014crossover comparative study with famotidine and low-dose lansoprazole","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2004.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}